Merotocin
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(3R,6S,9S,12S,15S)-6-(2-Amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-9-(3-amino-3-oxopropyl)-12-[(2S)-butan-2-yl]-N-[(4-fluorophenyl)methyl]-15-[(4-hydroxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carboxamide | |
| Identifiers | |
| CAS Number | 1190083-57-8 |
| ATC code | None |
| PubChem | CID 76073634 |
| ChemSpider | 34994563 |
| Synonyms | N-(4-Sulfanylbutanoyl)-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-N-[(4-fluorophenyl)methyl]glycyl-L-leucylglycinamide cyclic (1-5)-thioether |
| Chemical data | |
| Formula | C48H68FN11O12S |
| Molar mass | 1042.183423 g/mol |
| |
| |
Merotocin (INN) (developmental code name FE-202767), also known as carba-1-(4-FBzlGly7)dOT, is a potent (EC50 < 0.1 nM) and highly selective (>1000-fold over the related vasopressin receptors) peptidic agonist of the oxytocin receptor that was derived from oxytocin.[1][2][3] It is under development by Ferring Pharmaceuticals for the treatment of preterm mothers with lactation failure requiring lactation support, and is in phase II clinical trials for this indication.[3]
See also
References
- ↑ Manning, M.; Misicka, A.; Olma, A.; Bankowski, K.; Stoev, S.; Chini, B.; Durroux, T.; Mouillac, B.; Corbani, M.; Guillon, G. (2012). "Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics". Journal of Neuroendocrinology 24 (4): 609–628. doi:10.1111/j.1365-2826.2012.02303.x. ISSN 0953-8194.
- ↑ Yang, Yang; Li, Hao; Ward, Richard; Gao, Linghuan; Wei, Ji-Fu; Xu, Tian-Rui (2014). "Novel oxytocin receptor agonists and antagonists: a patent review (2002 – 2013)". Expert Opinion on Therapeutic Patents 24 (1): 29–46. doi:10.1517/13543776.2014.845168. ISSN 1354-3776.
- 1 2 Wiśniewski K, Alagarsamy S, Galyean R, Tariga H, Thompson D, Ly B, Wiśniewska H, Qi S, Croston G, Laporte R, Rivière PJ, Schteingart CD (2014). "New, potent, and selective peptidic oxytocin receptor agonists" (PDF). J. Med. Chem. 57 (12): 5306–17. doi:10.1021/jm500365s. PMID 24874785.
External links
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Thursday, October 29, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.